Olema Pharmaceuticals Inc (NASDAQ: OLMA) kicked off on Tuesday, up 136.38% from the previous trading day, before settling in for the closing price of $8.52. Over the past 52 weeks, OLMA has traded in a range of $2.86-$11.54.
During the last 5-year period, the sales drop of Healthcare Sector giant was -83.00%. While this was happening, its average annual earnings per share was recorded 11.28%. With a float of $52.95 million, this company’s outstanding shares have now reached $68.65 million.
Olema Pharmaceuticals Inc (OLMA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 22.89%, while institutional ownership is 86.41%. The most recent insider transaction that took place on Sep 18 ’25, was worth 83,300. In this transaction Director of this company sold 10,000 shares at a rate of $8.33, taking the stock ownership to the 744,140 shares. Before that another transaction happened on Sep 16 ’25, when Company’s Director sold 10,000 for $8.04, making the entire transaction worth $80,400. This insider now owns 754,140 shares in total.
Olema Pharmaceuticals Inc (OLMA) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.51 earnings per share (EPS), lower than consensus estimate (set at 0.17) by -0.68. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.50% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Take a look at Olema Pharmaceuticals Inc’s (OLMA) current performance indicators. Last quarter, stock had a quick ratio of 8.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.35 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Looking closely at Olema Pharmaceuticals Inc (NASDAQ: OLMA), its last 5-days average volume was 18.26 million, which is a jump from its year-to-date volume of 1.36 million. As of the previous 9 days, the stock’s Stochastic %D was 64.51%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 69.50%, which indicates a significant increase from 63.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.23 in the past 14 days, which was higher than the 0.62 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.19, while its 200-day Moving Average is $5.88. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $25.50. Second resistance stands at $30.87. The third major resistance level sits at $34.56. If the price goes on to break the first support level at $16.44, it is likely to go to the next support level at $12.75. Now, if the price goes above the second support level, the third support stands at $7.38.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
The company with the Market Capitalisation of 1.38 billion has total of 68,660K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -129,470 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -42,220 K.
